The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients

Autor: Daniela Alexandru-Abrams, Michelle Paff, Daniela A. Bota, Frank P.K. Hsu

Publikováno v: Paff, M; Alexandru-Abrams, D; Hsu, FPK; & Bota, DA. (2014). The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients. Human Vaccines and Immunotherapeutics, 10(11), 3322-3331. doi: 10.4161/21645515.2014.983002. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8194m480
Human vaccines & immunotherapeutics, vol 10, iss 11

© 2014 Taylor & Francis Group, LLC. Glioblastoma Multiforme (GBM) is the most common type of brain tumor and it is uniformly fatal. The community standard of treatment for this disease is gross or subtotal resection of the tumor, followed by radiati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d945baa63df0302cde24daabd8a7bb1d
http://www.escholarship.org/uc/item/8194m480

Recent duplication and positive selection of the GAGE gene family.

Autor: Yang Liu, Qiyun Zhu, Naishuo Zhu

Publikováno v: Genetica; May2008, Vol. 133 Issue 1, p31-35, 5p